|
"jl ko"的相關文件
顯示項目 1-6 / 6 (共1頁)
1
每頁顯示[10|25|50]項目
| 中山醫學大學 |
2017-01 |
The ERK-ZEB1 pathway mediates epithelial-mesenchymal transition in pemetrexed resistant lung cancer cells with suppression by vinca alkaloids.
|
LY, Chiu; IL, Hsin; TY, Yang; WW, Sung; JY, Chi; JT, Chang; JL, Ko; GT, Sheu |
| 中山醫學大學 |
2015 |
Oral fungal immunomodulatory protein-Flammulina velutipes has influence on pulmonary inflammatory process and potential treatment for allergic airway disease: A mouse model
|
PY, Chu; HL, Sun; JL, Ko; MS, Ku; LJ, Lin; YT, Lee; PF, Liao; HH, Pan; HL, Lu; KH, Lue |
| 臺北醫學大學 |
2014 |
The Expression of Ribonucleotide Reductase M2 in the Carcinogenesis of Uterine Cervix and Its Relationship with Clinicopathological Characteristics and Prognosis of Cancer Patients
|
YF, SU;TF, Wu;JL, Ko;HT, Tsai;YT, Tee1;MH, Chien;CH, Chou;WL, Lin;HY, Low;MY, Chou;SF, Yang;PH, Wang |
| 臺北醫學大學 |
2014 |
Correlation of plasma osteopontin and neutrophil gelatinase-associated lipocalin levels with the severity and clinical outcome of pelvic inflammatory disease
|
YT, Tee;PH, Wang;SF, Yang;HT, Tsai;SK, Lee;JL, Ko;LY, Lin;SC, Chen |
| 臺北醫學大學 |
2013 |
Increased concentrations of plasma growth arrest-specific 6 and its soluble tyrosine kinase receptor sAxl in Taiwanese women with pelvic inflammatory disease
|
SC, Chen;JL, Ko;SF, Yang;MY, Tsai;HT, Tsai;CH, Tang;PH, Wang |
| 中山醫學大學 |
2003 |
Analysis of NQO1, GSTP1, and MnSOD genetic polymorphisms on lung cancer risk in Taiwan
|
Lin, P; YM, Hsueh; JL, Ko; YF, Liang; KJ, Tsai; CY, Chen |
顯示項目 1-6 / 6 (共1頁)
1
每頁顯示[10|25|50]項目
|
